Jubilant Ingrevia Limited updates on acquisition of 40% stake in Zettaone Technologies
Jubilant Ingrevia · Chemicals & Petrochemicals
Key highlights
- Acquisition of 40% equity stake in Zettaone Technologies India Private Limited by JAEL via Share Subscription and Share Purchase Agreement executed on November 8, 2026.
- Option to increase shareholding to 51% during the next year under the SPA terms.
- Acquisition marks entry into Electronics Design and Manufacturing Services sector, complementing the company's semiconductor and electronics chemicals vertical.
Why it's rated notable: The filing confirms an executed SSPA for a 40% stake in Zettaone with an option to 51%, but it states no consideration amount and refers to the October 1, 2026 letter for the key terms, so the level stays at medium.
Original filing
Announcement under Regulation 30 (LODR)-Updates on Acquisition
Read the filing on BSE (PDF) →Companies guiding to strong growth
Ranked by management's own guidance on revenue and margins — not by us.
Aerospace & Defense
Sign up free to see all 6 →
See full rankingsRank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Other acquisition / merger filings this fortnight
- NHC Foods approves quarter results, 99.98% Sachmaas Foods investment, two appointments
- NHC Foods approves Sept 2026 quarter results, buys 99.98% of Sachmaas Foods
- Prime Fresh Limited reports Q2 & H1 FY27 revenue growth and improved margins
- Aastha Spintex completes 100% acquisition of Falcon Yarns; Q2 results approved
- Aastha Spintex completes acquisition of 100% of Falcon Yarns Private Limited
- Prestige Estates signs SPA to acquire 100% of Allure Developers Private Limited
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Summary written by Arthneeti from the company's filing with the stock exchange; check the original filing for full details. Arthneeti is a research and analytics platform, not a SEBI-registered investment adviser, and nothing here is a recommendation to buy or sell.